Glen Eagle Advisors, LLC Xencor Inc Transaction History

Glen Eagle Advisors, LLC

  • $546 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$18.21 - $24.5 $1,821 - $2,450
-100 Closed
0 $0
Q4 2018

Aug 13, 2024
SELL
$32.39 - $42.05 $3,239 - $4,205
-100 Closed
0 $0
Q1 2018

Aug 14, 2024
BUY
$21.18 - $33.78 $2,118 - $3,378
100 New
100 $3 Million
Q1 2018

Aug 13, 2024
BUY
$21.18 - $33.78 $2,118 - $3,378
100 New
100 $3 Million

Others Institutions Holding XNCR

# of Institutions
200
Shares Held
63.2M
Call Options Held
3.9K
Put Options Held
3K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.38B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email